Estrogen Receptor-α Polymorphisms and Predisposition to TMJ Disorder

详细信息    查看全文

• 作者：Margarete Cristiane Ribeiro-Dasilva ; Sé ; rgio Roberto Peres Line ; Maria Cristina Leme Godoy dos Santos ; Mariana Trevisani Arthuri ; Wei Hou ; Roger Benton Fillingim ; Cé ; lia Marisa Rizzatti Barbosa
• 关键词：Temporomandibular disorder ; sex hormones ; estrogen receptor ; polymorphism
• 刊名：The Journal of Pain
• 出版年：2009
• 出版时间：May 2009
• 年：2009
• 卷：10
• 期：5
• 页码：527-533
• 全文大小：133 K

文摘

Temporomandibular joint disorders (TMJD) affect women with greater frequency than men, and sex hormones may contribute to this female predominance. Therefore, this study investigated whether estrogen receptor-α (XbaI/PvuII) single nucleotide polymorphisms (SNPs) are associated with TMJD in women. DNA was obtained from 200 women with TMJD (100 with chronic pain and 100 with signs of TMJD but no pain) diagnosed according to the Research Diagnostic Criteria for Temporomandibular Disorder (RDC/TMD) and 100 control women without TMJD. Restriction fragment length polymorphisms of polymerase chain reaction products were used to analyze XbaI and PvuII SNPs in DNA fragments. A model directly characterizing specific DNA sequence variants based on the risk haplotypic structure implemented with the EM algorithm was used to analyze the data. The [GC] haplotype of the XbaI locus was significantly more prevalent in both TMJD groups when compared with the control group (P = .0012). Specifically, the [GC] haplotype was more prevalent within the painful TMJD group versus the control group (OR = 3.203, 95 % CI = 1.633, 6.284) and in the TMJD no pain versus the control group (OR = 2.51, 95 % CI = 1.267, 4.97). In conclusion, the presence of [GC] haplotype in the XbaI locus may increase the susceptibility of women to develop TMJD.

Perspective

This study suggests that a polymorphism in the estrogen receptor may increase the risk of women developing temporomandibular joint disorder. This finding may elucidate the interindividual differences in the contribution of estrogen to TMJD, the genetic influences on TMJD predisposition, and may serve as the basis for future treatment tailoring, which could enhance outcomes for these patients.